A project that dissects the molecular proceses that allow bacteria of the Burkholderia cepacia complex to attach to cells was…
Articles by Patricia Inácio, PhD
American Airlines and its partners announced having raised $1.1 million for the Cystic Fibrosis Foundation (CFF) during the annual American Airlines…
Trikafta significantly improved the lung function of cystic fibrosis patients after only two weeks of treatment, with the benefits…
The first two patients have been dosed in the SPAN clinical trial testing a new formulation of adrulipase, a yeast-derived…
AP-PA02, an experimental phage therapy for people with cystic fibrosis (CF) and chronic Pseudomonas aeruginosa respiratory infections, was well tolerated and reduced the bacterial load…
CDX-7108, an oral therapy being developed by Codexis for exocrine pancreatic insufficiency (EPI) — which is common in people…
The nonprofit Emily’s Entourage has awarded $220,000 to a project to develop a nonviral and inhalable gene therapy…
The European Commission (EC) has granted orphan drug designation to KB407, Krystal Biotech’s potential inhaled gene therapy for cystic fibrosis (CF).
A Phase 2 trial of ACG-701, an investigational oral treatment for pulmonary exacerbations in people with cystic fibrosis (CF), is…
Physical activity increases fat-free mass — the lean mass in muscles, organs, bones, ligaments and tendons — in adolescents with…